2018 All Hands Meeting
October 15 Session
Sectors: Life Sciences & Fintech Track Agenda

9:00AM-10:00AM   Room 209
Managing the Blind Spots – Cross-Industry Alliances

Joshua Hofheimer
Sidley Austin LLP
SPEAKER BIOGRAPHIES

As companies explore new technologies and commercial channels outside their core competencies, many consider strategic partnerships to bring industry expertise to their new ventures. Today, we see a growing number of collaborations between technology and life sciences/biotech/medical device companies, which can raise a host of challenges and hurdles and uncover issues or gaps in their core business. Tech companies are accustomed to moving at fast pace and are not used to working within a regulatory framework that life sciences companies confront every day. Sidley Austin partner, Josh Hofheimer will discuss key considerations when collaborating across industries, lessons learned on how to best manage challenges and “blind spots.”

10:30AM-11:15 AM   Room 209
FDA Update: Gene Therapy, Genome Editing and Beyond

Emily Marden
Sidley Austin LLP
SPEAKER BIOGRAPHIES

It seems that every day we are hearing about the promise of new developments in genetic technologies for everything from curing cancer to ensuring global food security. Gene therapy and genome editing are being utilized in an effort to cure intractable human diseases such as cancer and hemophilia. And genome editing has become the go-to tool for innovation in the food and agriculture sector. FDA and USDA are taking steps to ensure that their regulatory framework is relevant and responsive to these potent genomic technologies and concerns that stakeholders might have. In this presentation we will assess the evolving regulatory landscape and discuss potential challenges for development of commercial products.

11:15AM-12:00PM   Room 209
Life Science IP Developments in the US and Europe

Brian Schar & Sandeep Birdi
CrossPond Law
SPEAKER BIOGRAPHIES

A cross-Atlantic survey of recent UK and US developments affecting life science companies, plus some important drafting tips to help life science companies in the European Patent Office.

1:30PM-2:15PM   Room 209
Distributed Ledger Technology: A Guide for the Perplexed

Samuel Dibble/Navin Sethi/Robert MacInnis
Baker Botts LLP/EY/ActiveAether
SPEAKER BIOGRAPHIES

An easy to understand overview of cryptocurrencies, tokens, blockchain and other applications of distributed ledger technology. Learn about exciting recent developments in the use of this technology and innovations in how funds are raised, including recent trends in ICOs, SAFTs and token pre-sales. We will also discuss the securities, tax and consumer protection issues raised by these innovations.

2:20PM-3:05PM   Room 209
Fintech and Europe: Navigating Legal and Regulatory Challenges in the EU

Gina Conheady & John Whelan
A&L Goodbody
SPEAKER BIOGRAPHIES

Tech savvy in-house counsel know that the fintech technological revolution is global, but that regulations and commercial standards of nations and multinational blocs are not all adapting at the same pace, or in the same ways. Whether you're counsel of a fintech company, or of a company that relies upon or engages with fintech companies, this presentation will give you an overview of the regulatory landscape in Europe and the key differences between the US and EU regimes in this area.

3:30PM-4:30PM   Room 210
Identifying and Managing Risks in an Era of Global Compliance

Matthew Jacobs & Jessica Heim/Landon Edmond
Vinson & Elkins LLP/SAP Cloud Business Group
SPEAKER BIOGRAPHIES

In what is becoming an ever increasing global world, companies must be well-positioned to identify, mitigate and manage compliance risks on an international level. This panel discussion will walk through risk scenarios, tips for identifying risks proactively, and lessons learned from the defense side when things go awry. The panelists offer both in-house perspective on tackling the massive job of managing a legal department on a global level in a quickly evolving technology sector as well as insight when defending companies and their compliance programs to government regulators, and effective ways to both develop and implement an effective global compliance program.


Please Note: Program details are subject to change without notice

2018 Participating Law Firms & Companies